Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS)
CNY 29.07
(7.11%)
CNY 29.07
(7.11%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 545.28 Million CNY | -11.94% |
| 2022 | 619.24 Million CNY | -21.82% |
| 2021 | 792.09 Million CNY | 2.79% |
| 2020 | 770.59 Million CNY | -7.5% |
| 2019 | 833.09 Million CNY | 30.43% |
| 2018 | 638.73 Million CNY | 19.39% |
| 2017 | 534.99 Million CNY | -10.57% |
| 2016 | 598.2 Million CNY | -1.04% |
| 2015 | 604.51 Million CNY | 22.57% |
| 2014 | 493.21 Million CNY | 41.45% |
| 2013 | 348.69 Million CNY | 3.72% |
| 2012 | 336.17 Million CNY | 31.88% |
| 2011 | 254.92 Million CNY | 42.97% |
| 2010 | 178.3 Million CNY | 36.72% |
| 2009 | 130.41 Million CNY | 34.92% |
| 2008 | 96.66 Million CNY | 40.58% |
| 2007 | 68.75 Million CNY | 14.5% |
| 2006 | 60.05 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 121.92 Million CNY | -26.05% |
| 2024 Q2 | 181.78 Million CNY | 49.09% |
| 2024 Q3 | 170.99 Million CNY | -12.75% |
| 2023 Q1 | 126.64 Million CNY | -28.98% |
| 2023 Q3 | 134.41 Million CNY | -16.59% |
| 2023 FY | 545.28 Million CNY | -11.94% |
| 2023 Q4 | 164.88 Million CNY | 22.67% |
| 2023 Q2 | 161.14 Million CNY | 27.24% |
| 2022 FY | 619.24 Million CNY | -21.82% |
| 2022 Q4 | 178.32 Million CNY | 21.97% |
| 2022 Q3 | 146.2 Million CNY | -7.7% |
| 2022 Q2 | 158.39 Million CNY | 16.19% |
| 2022 Q1 | 136.32 Million CNY | -37.94% |
| 2021 Q3 | 162.17 Million CNY | -26.03% |
| 2021 Q2 | 219.24 Million CNY | 14.79% |
| 2021 Q1 | 191 Million CNY | -11.51% |
| 2021 FY | 792.09 Million CNY | 2.79% |
| 2021 Q4 | 219.67 Million CNY | 35.46% |
| 2020 Q2 | 194.38 Million CNY | 13.53% |
| 2020 Q3 | 189.13 Million CNY | -2.7% |
| 2020 Q4 | 215.85 Million CNY | 14.12% |
| 2020 FY | 770.59 Million CNY | -7.5% |
| 2020 Q1 | 171.21 Million CNY | -7.1% |
| 2019 Q2 | 306.12 Million CNY | 91.82% |
| 2019 FY | 833.09 Million CNY | 30.43% |
| 2019 Q4 | 184.3 Million CNY | 0.67% |
| 2019 Q3 | 183.08 Million CNY | -40.19% |
| 2019 Q1 | 159.58 Million CNY | 0.0% |
| 2018 FY | 638.73 Million CNY | 19.39% |
| 2017 FY | 534.99 Million CNY | -10.57% |
| 2016 FY | 598.2 Million CNY | -1.04% |
| 2015 FY | 604.51 Million CNY | 22.57% |
| 2014 FY | 493.21 Million CNY | 41.45% |
| 2013 Q1 | 89.09 Million CNY | -13.79% |
| 2013 Q2 | 92.81 Million CNY | 4.18% |
| 2013 Q3 | 114.6 Million CNY | 23.47% |
| 2013 FY | 348.69 Million CNY | 3.72% |
| 2012 Q2 | 80.55 Million CNY | 18.99% |
| 2012 FY | 336.17 Million CNY | 31.88% |
| 2012 Q4 | 103.33 Million CNY | 22.16% |
| 2012 Q3 | 84.58 Million CNY | 5.01% |
| 2012 Q1 | 67.69 Million CNY | -2.58% |
| 2011 Q2 | 61.69 Million CNY | 35.66% |
| 2011 Q4 | 69.49 Million CNY | -11.18% |
| 2011 Q1 | 45.48 Million CNY | -15.84% |
| 2011 FY | 254.92 Million CNY | 42.97% |
| 2011 Q3 | 78.24 Million CNY | 26.82% |
| 2010 Q1 | 37.07 Million CNY | 0.0% |
| 2010 Q2 | 41.44 Million CNY | 11.78% |
| 2010 Q4 | 54.03 Million CNY | 18.13% |
| 2010 FY | 178.3 Million CNY | 36.72% |
| 2010 Q3 | 45.74 Million CNY | 10.38% |
| 2009 FY | 130.41 Million CNY | 34.92% |
| 2008 FY | 96.66 Million CNY | 40.58% |
| 2007 FY | 68.75 Million CNY | 14.5% |
| 2006 FY | 60.05 Million CNY | 0.0% |